)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Tilray Brands
Tilray Brands (TLRY) investor relations material
Tilray Brands Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 earnings summary8 Oct, 2026
Executive summary
Record Q1 FY2027 revenue was $257.1M, up 23% YoY; gross profit rose 35% to $77.5M and gross margin expanded to 30% from 27%.
Beverage and distribution growth offset lower cannabis revenue; net loss was $40.0M and adjusted EBITDA was $9.2M.
FY2027 adjusted EBITDA guidance was reaffirmed at $68M–$75M; debt decreased $42M fiscal year to date.
Financial highlights
Revenue increased from $209.5M to $257.1M; gross profit rose from $57.5M to $77.5M.
Operating loss was $24.1M versus operating income of $2.1M; operating expenses increased 83% to $101.6M.
Net loss was $40.0M, or $0.32 per share; adjusted net loss was $3.0M, or adjusted EPS of $(0.02).
Adjusted EBITDA was $9.2M versus $10.2M, down 10% YoY; global fuel surcharges reduced results by $1.7M.
Operating cash outflow was $16.5M versus $1.3M; free cash flow was $(27.4)M versus $(10.6)M.
Outlook and guidance
FY2027 adjusted EBITDA guidance was reaffirmed at $68M–$75M, representing expected double-digit growth versus FY2026.
Results are expected to be weighted toward H2, with significant strengthening in Q4; new Canadian cultivars are expected to contribute more late in Q2 and beyond.
Portugal is expected to deliver more than 40 metric tons of flower at full capacity in FY2027.
Carlsberg brand production, marketing, sales and U.S. distribution are scheduled to begin January 1, 2027.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tilray Brands
- Virtual meeting to elect directors, ratify auditor, and approve Board declassification.TLRY
Proxy filing - Key votes include board declassification, annual director elections, and auditor ratification.TLRYProxy filing
- Virtual meeting to vote on board declassification, director elections, and auditor ratification.TLRYProxy filing
- Record revenue and adjusted EBITDA highlight strong growth and international expansion.TLRYQ4 2026
- Acquisition creates a $500M global craft beverage platform, driving EBITDA and international growth.TLRYM&A announcement
- Revenue rose 13% to $200M as gross margin expanded to 30%.TLRYQ1 2025
- Record revenue growth, margin gains, and cost synergies support a strong FY2025 outlook.TLRYQ4 2024
- Q3 net revenue was $185.8M, with improved margins but a $793.5M net loss from impairments.TLRYQ3 2025
- Record $211M Q2 revenue, with margin growth led by beverages and international cannabis.TLRYQ2 2025
Next Tilray Brands earnings date
Q2 20277 Jan, 2027
Tilray Brands
Next Tilray Brands earnings date
Q2 20277 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It offers sativa, indica, and hybrid medical marijuana grown and sold under the Tilray brand; cannabis oils; capsules; and accessories for administration of medical cannabis including oral syringes and syringe applicators. The company also provides Tetrahydrocannabinol, Cannabidiol, Sativa, Indica, Hybrid, CBD Energy Shot; Live Resin Vape Pen Cartridges; and Cannabis oil. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.